KRM Ayurveda Ltd Q2 FY27 Profit Rises 95.2% to ₹8.2 Crore

KRM Ayurveda Ltd reported Q2 FY27 net profit of ₹8.2 crore, up 95.2% year-on-year, as revenue from operations increased 46.4% to ₹34.7 crore for the quarter ended September 30, 2026. The results show faster profit growth than revenue growth compared with the same quarter last year, while profitability was lower than in the immediately preceding quarter.

What did KRM Ayurveda report for Q2 FY27?

KRM Ayurveda reported total income of ₹35.4 crore in Q2 FY27, including ₹34.7 crore of revenue from operations and ₹0.6 crore of other income. Net profit stood at ₹8.2 crore, compared with ₹4.2 crore in Q2 FY26 and ₹9.1 crore in Q1 FY27. Profit before tax was ₹10.9 crore, against ₹5.6 crore a year earlier.

The company filed its results with the National Stock Exchange on November 13, 2026. The quarterly results table describes the figures as standalone. A separate summary of the September 2026 quarter refers to consolidated revenue of ₹34.66 crore and profit after tax of ₹8.15 crore, which round to the ₹34.7 crore and ₹8.2 crore figures shown in the results snapshot.

How did revenue and profitability change from last year?

KRM Ayurveda's revenue from operations rose 46.4% year-on-year from ₹23.7 crore to ₹34.7 crore. Net profit increased 95.2% from ₹4.2 crore to ₹8.2 crore, while operating profit grew 87.3% year-on-year, according to the filing-derived data. The reported profit growth therefore exceeded the increase in operating revenue during the period.

Operating margin, which excludes other income, improved to 30.8% in Q2 FY27 from 23.5% in Q2 FY26. The 7.3 percentage-point year-on-year increase indicates that operating profitability improved alongside revenue growth. Other income was ₹0.6 crore in the latest quarter, compared with ₹0.1 crore in the year-earlier period, while the operating margin measure itself excludes this item.

Why was profit lower than in the June 2026 quarter?

KRM Ayurveda's net profit was 9.9% lower quarter-on-quarter than the ₹9.1 crore reported in Q1 FY27, and operating profit declined 12.0% on the same basis. Profit before tax fell from ₹12.2 crore in Q1 FY27 to ₹10.9 crore in Q2 FY27, despite revenue from operations increasing from ₹32.3 crore to ₹34.7 crore.

The operating margin declined from 37.1% in Q1 FY27 to 30.8% in Q2 FY27. This was a 6.3 percentage-point sequential reduction, although the margin remained above the 23.5% recorded in Q2 FY26. The available results information does not provide a detailed explanation for the quarter-on-quarter movement in margin or profit, so the filing supports comparison rather than a conclusion on its cause.

What does the filing say about cash flow and reporting context?

KRM Ayurveda reported standalone operating cash flow of negative ₹4.53 crore for the first half of FY27. Operating cash flow measures cash generated or used by regular business activities and is separate from the quarterly accounting profit reported in the income statement.

The filing summary also states that prior figures were restated and that the year-ago quarter was not reviewed. These disclosures are relevant when comparing periods because restated figures may differ from numbers previously presented. Investors assessing the results may therefore distinguish between the strong year-on-year income statement growth and the negative first-half operating cash flow disclosed in the same material.

How do these results matter for investors and operations?

The Q2 outcome shows that KRM Ayurveda generated ₹34.7 crore in revenue and ₹8.2 crore in net profit during the September quarter, with both figures materially above the corresponding prior-year period. The increase in operating margin from 23.5% to 30.8% also points to stronger year-on-year operating profitability based on the reported figures.

For investors, the sequential comparison provides a second part of the picture. Revenue was higher than in Q1 FY27, but net profit, profit before tax and operating margin were lower. No share-price movement, management commentary, clinic-opening update, or detailed expense breakdown was included in the supplied results data, limiting conclusions about the drivers of the quarterly change.

Conclusion

KRM Ayurveda delivered year-on-year growth in Q2 FY27, with revenue from operations rising 46.4% to ₹34.7 crore and net profit increasing 95.2% to ₹8.2 crore. Operating margin improved substantially from a year earlier, but declined from the June 2026 quarter, while standalone operating cash flow for the first half was negative ₹4.53 crore.

The next assessment will depend on subsequent quarterly disclosures, particularly whether revenue growth, operating margin and cash generation develop consistently. Readers should also watch for any further clarification in future filings on the scope of reported figures, the effect of restated prior numbers, and the reasons for sequential changes in profitability.